You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Express Scripts
Medtronic
AstraZeneca
Dow

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for levonordefrin; mepivacaine hydrochloride and what is the scope of patent protection?

Levonordefrin; mepivacaine hydrochloride is the generic ingredient in six branded drugs marketed by Solvay, Eastman Kodak, Septodont Inc, Belmora Llc, Dentsply Pharm, and Deproco, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for levonordefrin; mepivacaine hydrochloride. One supplier is listed for this compound.

Summary for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
Recent Clinical Trials for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Sao PauloN/A
Novalar Pharmaceuticals, Inc.Phase 2

See all LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE clinical trials

Pharmacology for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm POLOCAINE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 089517-001 Apr 14, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Eastman Kodak CARBOCAINE W/ NEO-COBEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 012125-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Septodont Inc ISOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 084697-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKesson
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.